The three-layer concentric model of glioblastoma: Cancer stem cells, microenvironmental regulation, and therapeutic implications

TheScientificWorldJournal

Volumn 11, Issue , 2011, Pages 1829-1841

  Persano, Luca ^a   Rampazzo, Elena ^a   Della Puppa, Alessandro ^a   Pistollato, Francesca ^a   Basso, Giuseppe ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

cancer stem cells; chemotherapy resistance; Hypoxia; topographic distribution

Indexed keywords

ANTINEOPLASTIC AGENT; CARMUSTINE; CD133 ANTIGEN; CHEMOKINE RECEPTOR CXCR4; HYPOXIA INDUCIBLE FACTOR 1ALPHA; KRUPPEL LIKE FACTOR 4; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; MYC PROTEIN; NESTIN; NOTCH RECEPTOR; OCTAMER TRANSCRIPTION FACTOR 4; OXYGEN; TRANSCRIPTION FACTOR SOX2;

ARTICLE; BRAIN OXYGEN TENSION; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER GRADING; CANCER GROWTH; CANCER INVASION; CANCER RADIOTHERAPY; CANCER STEM CELL; CANCER SURGERY; CELL DIFFERENTIATION; CELL FRACTIONATION; CELL FUNCTION; CELL MIGRATION; CELL VIABILITY; CELLULAR DISTRIBUTION; ENZYME ACTIVITY; ENZYME STABILITY; GLIOBLASTOMA; HEMATOPOIETIC STEM CELL; HUMAN; HYPOXIA; IN VITRO STUDY; METHYLATION; NEUROSURGERY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PHENOTYPE; PROGNOSIS; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SURGEON; TISSUE OXYGENATION; TUMOR MICROENVIRONMENT; TUMOR RECURRENCE; TUMOR VASCULARIZATION; TUMOR VOLUME;

BRAIN NEOPLASMS; CELL HYPOXIA; GLIOBLASTOMA; HUMANS; NEOPLASTIC STEM CELLS;

EID: 81455142965     PISSN: None     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1100/2011/736480     Document Type: Article

References (109)

1. Raymond J., Segre D., The effect of oxygen on biochemical networks and the evolution of complex life Science 2006 311 5768 1764 1767
2. Simon M. C., Keith B., The role of oxygen availability in embryonic development and stem cell function Nature Reviews Molecular Cell Biology 2008 9 4 285 296 (Pubitemid 351430845)
3. Hoge R. D., Pike G. B., Oxidative metabolism and the detection of neuronal activation via imaging Journal of Chemical Neuroanatomy 2001 22 1-2 43 52 (Pubitemid 32695508)
4. Pistollato F., Chen H. L., Schwartz P. H., Basso G., Panchision D. M., Oxygen tension controls the expansion of human CNS precursors and the generation of astrocytes and oligodendrocytes Molecular and Cellular Neuroscience 2007 35 3 424 435 (Pubitemid 46992832)
5. Smith J., Ladi E., Mayer-Proschel M., Noble M., Redox state is a central modulator of the balance between self-renewal and differentiation in a dividing glial precursor cell Proceedings of the National Academy of Sciences of the United States of America 2000 97 18 10032 10037
6. Morrison S. J., Csete M., Groves A. K., Melega W., Wold B., Anderson D. J., Culture in reduced levels of oxygen promotes clonogenic sympathoadrenal differentiation by isolated neural crest stem cells Journal of Neuroscience 2000 20 19 7370 7376
7. Storch A., Paul G., Csete M., Boehm B. O., Carvey P. M., Kupsch A., Schwarz J., Long-term proliferation and dopaminergic differentiation of human mesencephalic neural precursor cells Experimental Neurology 2001 170 2 317 325 (Pubitemid 32758685)
8. Studer L., Csete M., Lee S. H., Kabbani N., Walikonis J., Wold B., McKay R., Enhanced proliferation, survival, and dopaminergic differentiation of CNS precursors in lowered oxygen Journal of Neuroscience 2000 20 19 7377 7383
9. Milosevic J., Schwarz S. C., Krohn K., Poppe M., Storch A., Schwarz J., Low atmospheric oxygen avoids maturation, senescence and cell death of murine mesencephalic neural precursors Journal of Neurochemistry 2005 92 4 718 729 (Pubitemid 40229543)
10. Vescovi A. L., Galli R., Reynolds B. A., Brain tumour stem cells Nature Reviews Cancer 2006 6 6 425 436
11. Eriksson P. S., Perfilieva E., Bjork-Eriksson T., Alborn A. M., Nordborg C., Peterson D. A., Gage F. H., Neurogenesis in the adult human hippocampus Nature Medicine 1998 4 11 1313 1317 (Pubitemid 28512114)
12. Ignatova T. N., Kukekov V. G., Laywell E. D., Suslov O. N., Vrionis F. D., Steindler D. A., Human cortical glial tumors contain neural stem-like cells expressing astroglial and neuronal markers in vitro GLIA 2002 39 3 193 206
13. Tamaki S., Eckert K., He D., Sutton R., Doshe M., Jain G., Tushinski R., Reitsma M., Harris B., Tsukamoto A., Gage F., Weissman I., Uchida N., Engraftment of sorted/expanded human central nervous system stem cells from fetal brain Journal of Neuroscience Research 2002 69 6 976 986 (Pubitemid 34984715)
14. Ljungkvist A. S. E., Bussink J., Kaanders J. H. A. M., van der Kogel A. J., Dynamics of tumor hypoxia measured with bioreductive hypoxic cell markers Radiation Research 2007 167 2 127 145 (Pubitemid 46214661)
15. Wang G. L., Jiang B. H., Rue E. A., Semenza G. L., Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O 2 tension Proceedings of the National Academy of Sciences of the United States of America 1995 92 12 5510 5514
16. Birner P., Gatterbauer B., Oberhuber G., Schindl M., Rssler K., Prodinger A., Budka H., Hainfellner J. A., Expression of hypoxia-inducible factor-1 in oligodendrogliomas: its impact on prognosis and on neoangiogenesis Cancer 2001 92 1 165 171 (Pubitemid 32623053)
17. Eckert A. W., Schutze A., Lautner M. H. W., Taubert H., Schubert J., Bilkenroth U., HIF-1 is a prognostic marker in oral squamous cell carcinomas International Journal of Biological Markers 2010 25 2 87 92
18. Flynn J. R., Wang L., Gillespie D. L., Stoddard G. J., Reid J. K., Owens J., Ellsworth G. B., Salzman K. L., Kinney A. Y., Jensen R. L., Hypoxia-regulated protein expression, patient characteristics, and preoperative imaging as predictors of survival in adults with glioblastoma multiforme Cancer 2008 113 5 1032 1042
19. Liang X., Zheng M., Jiang J., Zhu G., Yang J., Tang Y., Hypoxia-inducible factor-1 alpha, in association with TWIST2 and SNIP1, is a critical prognostic factor in patients with tongue squamous cell carcinoma Oral Oncology 2010 47 92 97
20. Qiu M. Z., Han B., Luo H. Y., Zhou Z. W., Wang Z. Q., Wang F. H., Li Y. H., Xu R. H., Expressions of hypoxia-inducible factor-1 and hexokinase-II in gastric adenocarcinoma: the impact on prognosis and correlation to clinicopathologic features Tumor Biology 2010 32 159 166
21. Seeber L. M. S., Horree N., van der Groep P., van der Wall E., Verheijen R. H. M., van Diest P. J., Necrosis related HIF-1 expression predicts prognosis in patients with endometrioid endometrial carcinoma BMC Cancer 2010 10, article 307
22. Szkandera J., Knechtel G., Stotz M., Hofmann G., Langsenlehner U., Krippl P., Langsenlehner T., Dehchamani D., Samonigg H., Renner W., Gerger A., Association of hypoxia-inducible factor 1-alpha gene polymorphisms and colorectal cancer prognosis Anticancer Research 2010 30 6 2393 2397
23. Gillespie D. L., Whang K., Ragel B. T., Flynn J. R., Kelly D. A., Jensen R. L., Silencing of hypoxia inducible factor-1 by RNA interference attenuates human glioma cell growth in vivo Clinical Cancer Research 2007 13 8 2441 2448 (Pubitemid 46698595)
24. Holmquist-Mengelbier L., Fredlund E., Lofstedt T., Noguera R., Navarro S., Nilsson H., Pietras A., Vallon-Christersson J., Borg., Gradin K., Poellinger L., Phlman S., Recruitment of HIF-1 and HIF-2 to common target genes is differentially regulated in neuroblastoma: HIF-2 promotes an aggressive phenotype Cancer Cell 2006 10 5 413 423 (Pubitemid 44693470)
25. Semenza G. L., Involvement of hypoxia-inducible factor 1 in human cancer Internal Medicine 2002 41 2 79 83 (Pubitemid 34223708)
26. Semenza G. L., Targeting HIF-1 for cancer therapy Nature Reviews Cancer 2003 3 10 721 732 (Pubitemid 37328811)
27. Vaupel P., The role of hypoxia-induced factors in tumor progression Oncologist 2004 9 5 10 17 (Pubitemid 39658341)
28. Lpez-Lzaro M., Does hypoxia really control tumor growth? Cellular Oncology 2006 28 5-6 327 329
29. Xu R. H., Pelicano H., Zhou Y., Carew J. S., Feng L., Bhalla K. N., Keating M. J., Huang P., Inhibition of glycolysis in cancer cells: a novel strategy to overcome drug resistance associated with mitochondrial respiratory defect and hypoxia Cancer Research 2005 65 2 613 621
30. Chandel N. S., McClintock D. S., Feliciano C. E., Wood T. M., Melendez J. A., Rodriguez A. M., Schumacker P. T., Reactive oxygen species generated at mitochondrial complex III stabilize hypoxia-inducible factor-1 during hypoxia: a mechanism of O 2 sensing Journal of Biological Chemistry 2000 275 33 25130 25138
31. Semenza G. L., Hypoxia-inducible factor 1 and cancer pathogenesis IUBMB Life 2008 60 9 591 597
32. Maxwell P. H., Dachs G. U., Gleadle J. M., Nicholls L. G., Harris A. L., Stratford I. J., Hankinson O., Pugh C. W., Ratcliffe P. J., Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth Proceedings of the National Academy of Sciences of the United States of America 1997 94 15 8104 8109 (Pubitemid 27343784)
33. Gustafsson M. V., Zheng X., Pereira T., Gradin K., Jin S., Lundkvist J., Ruas J. L., Poellinger L., Lendahl U., Bondesson M., Hypoxia requires Notch signaling to maintain the undifferentiated cell state Developmental Cell 2005 9 5 617 628 (Pubitemid 41555144)
34. Land S. C., Tee A. R., Hypoxia-inducible factor 1 is regulated by the mammalian target of rapamycin (mTOR) via an mTOR signaling motif Journal of Biological Chemistry 2007 282 28 20534 20543 (Pubitemid 47100043)
35. Pistollato F., Chen H. L., Rood B. R., Zhang H. Z., D'Avella D., Denaro L., Gardiman M., Te Kronnie G., Schwartz P. H., Favaro E., Indraccolo S., Basso G., Panchision D. M., Hypoxia and HIF1 repress the differentiative effects of BMPs in high-grade glioma Stem Cells 2009 27 1 7 17
36. Sneddon J. B., Werb Z., Location, location, location: the cancer stem cell niche Cell Stem Cell 2007 1 6 607 611 (Pubitemid 350215340)
37. Denysenko T., Gennero L., Roos M. A., Melcarne A., Juenemann C., Faccani G., Morra I., Cavallo G., Reguzzi S., Pescarmona G., Ponzetto A., Glioblastoma cancer stem cells: heterogeneity, microenvironment and related therapeutic strategies Cell Biochemistry and Function 2010 28 5 343 351
38. Stupp R., Mason W. P., van Den Bent M. J., Weller M., Fisher B., Taphoorn M. J. B., Belanger K., Brandes A. A., Marosi C., Bogdahn U., Curschmann J., Janzer R. C., Ludwin S. K., Gorlia T., Allgeier A., Lacombe D., Cairncross J. G., Eisenhauer E., Mirimanoff R. O., Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma The New England Journal of Medicine 2005 352 10 987 996 (Pubitemid 40349501)
39. Hassler M., Seidl S., Fazeny-Doerner B., Preusser M., Hainfellner J., Rssler K., Prayer D., Marosi C., Diversity of cytogenetic and pathohistologic profiles in glioblastoma Cancer Genetics and Cytogenetics 2006 166 1 46 55
40. Huang Z., Cheng L., Guryanova O. A., Wu Q., Bao S., Cancer stem cells in glioblastomamolecular signaling and therapeutic targeting Protein Cell 2010 1 638 655
41. Galli R., Binda E., Orfanelli U., Cipelletti B., Gritti A., De Vitis S., Fiocco R., Foroni C., Dimeco F., Vescovi A., Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma Cancer Research 2004 64 19 7011 7021 (Pubitemid 39331011)
42. Singh S. K., Hawkins C., Clarke I. D., Squire J. A., Bayani J., Hide T., Henkelman R. M., Cusimano M. D., Dirks P. B., Identification of human brain tumour initiating cells Nature 2004 432 7015 396 401 (Pubitemid 39551674)
43. Gilbertson R. J., Rich J. N., Making a tumour's bed: glioblastoma stem cells and the vascular niche Nature Reviews Cancer 2007 7 10 733 736 (Pubitemid 47463683)
44. Calabrese C., Poppleton H., Kocak M., Hogg T. L., Fuller C., Hamner B., Oh E. Y., Gaber M. W., Finklestein D., Allen M., Frank A., Bayazitov I. T., Zakharenko S. S., Gajjar A., Davidoff A., Gilbertson R. J., A perivascular niche for brain tumor stem cells Cancer Cell 2007 11 1 69 82 (Pubitemid 46054518)
45. Heddleston J. M., Li Z., Lathia J. D., Bao S., Hjelmeland A. B., Rich J. N., Hypoxia inducible factors in cancer stem cells The British Journal of Cancer 2010 102 5 789 795
46. Heddleston J. M., Li Z., McLendon R. E., Hjelmeland A. B., Rich J. N., The hypoxic microenvironment maintains glioblastoma stem cells and promotes reprogramming towards a cancer stem cell phenotype Cell Cycle 2009 8 20 3274 3284
47. Li Z., Bao S., Wu Q., Wang H., Eyler C., Sathornsumetee S., Shi Q., Cao Y., Lathia J., McLendon R. E., Hjelmeland A. B., Rich J. N., Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells Cancer Cell 2009 15 6 501 513
48. Piccirillo S. G. M., Combi R., Cajola L., Patrizi A., Redaelli S., Bentivegna A., Baronchelli S., Maira G., Pollo B., Mangiola A., DiMeco F., Dalpr L., Vescovi A. L., Distinct pools of cancer stem-like cells coexist within human glioblastomas and display different tumorigenicity and independent genomic evolution Oncogene 2009 28 15 1807 1811
49. Olumi A. F., Grossfeld G. D., Hayward S. W., Carroll P. R., Tlsty T. D., Cunha G. R., Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium Cancer Research 1999 59 19 5002 5011 (Pubitemid 29472907)
50. Sneddon J. B., Zhen H. H., Montgomery K., Van De Rijn M., Tward A. D., West R., Gladstone H., Chang H. Y., Morganroth G. S., Oro A. E., Brown P. O., Bone morphogenetic protein antagonist gremlin 1 is wideley expressed by cancer-associated stromal cells and can promote tumor cell proliferation Proceedings of the National Academy of Sciences of the United States of America 2006 103 40 14842 14847 (Pubitemid 44527816)
51. De Toni F., Racaud-Sultan C., Chicanne G., Mas V. M. D., Cariven C., Mesange F., Salles J. P., Demur C., Allouche M., Payrastre B., Manenti S., Ysebaert L., A crosstalk between the Wnt and the adhesion-dependent signaling pathways governs the chemosensitivity of acute myeloid leukemia Oncogene 2006 25 22 3113 3122 (Pubitemid 43881553)
52. Jin L., Hope K. J., Zhai Q., Smadja-Joffe F., Dick J. E., Targeting of CD44 eradicates human acute myeloid leukemic stem cells Nature Medicine 2006 12 10 1167 1174 (Pubitemid 44527352)
53. Krause D. S., Lazarides K., von Andrian U. H., Van Etten R. A., Requirement for CD44 in homing and engraftment of BCR-ABL-expressing leukemic stem cells Nature Medicine 2006 12 10 1175 1180 (Pubitemid 44527353)
54. Hambardzumyan D., Becher O. J., Rosenblum M. K., Pandolfi P. P., Manova-Todorova K., Holland E. C., PI3K pathway regulates survival of cancer stem cells residing in the perivascular niche following radiation in medulloblastoma in vivo Genes and Development 2008 22 4 436 448 (Pubitemid 351272752)
55. Indraccolo S., Minuzzo S., Masiero M., Pusceddu I., Persano L., Moserle L., Reboldi A., Favaro E., Mecarozzi M., Di Mario G., Screpanti I., Ponzoni M., Doglioni C., Amadori A., Cross-talk between tumor and endothelial cells involving the Notch3-DII4 interaction marks escape from tumor dormancy Cancer Research 2009 69 4 1314 1323
56. Pistollato F., Rampazzo E., Persano L., Abbadi S., Frasson C., Denaro L., D'Avella D., Panchision D. M., Puppa A. D., Scienza R., Basso G., Interaction of hypoxia-inducible factor-1 and Notch signaling regulates medulloblastoma precursor proliferation and fate Stem Cells 2010 28 11 1918 1929
57. Leventhal C., Rafii S., Rafii D., Shahar A., Goldman S. A., Endothelial trophic support of neuronal production and recruitment from the adult mammalian subependyma Molecular and Cellular Neurosciences 1999 13 6 450 464 (Pubitemid 29337211)
58. Ramirez-Castillejo C., Sanchez-Sanchez F., Andreu-Agullo C., Pigment epithelium-derived factor is a niche signal for neural stem cell renewal Nature Neuroscience 2006 9 331 339 (Pubitemid 43290962)
59. Le Bras B., Barallobre M. J., Homman-Ludiye J., Ny A., Wyns S., Tammela T., Haiko P., Karkkainen M. J., Yuan L., Muriel M. P., Chatzopoulou E., Bréant C., Zalc B., Carmeliet P., Alitalo K., Eichmann A., Thomas J. L., VEGF-C is a trophic factor for neural progenitors in the vertebrate embryonic brain Nature Neuroscience 2006 9 3 340 348 (Pubitemid 43290963)
60. Charles N., Ozawa T., Squatrito M., Bleau A. M., Brennan C. W., Hambardzumyan D., Holland E. C., Perivascular nitric oxide activates notch signaling and promotes stem-like character in PDGF-induced glioma cells Cell Stem Cell 2010 6 2 141 152
61. Takano S., Yamashita T., Ohneda O., Molecular therapeutic targets for glioma angiogenesis Journal of Oncology 2010
62. Chow D. C., Wenning L. A., Miller W. M., Papoutsakis E. T., Modeling pO 2 distributions in the bone marrow hematopoietic compartment. II. Modified Kroghian models Biophysical Journal 2001 81 2 685 696 (Pubitemid 32721444)
63. Chow D. C., Wenning L. A., Miller W. M., Papoutsakis E. T., Modeling pO2 distributions in the bone marrow hematopoietic compartment. I. Krogh's model Biophysical Journal 2001 81 2 675 684 (Pubitemid 32721443)
64. Cipolleschi M. G., Sbarba P. D., Olivotto M., The role of hypoxia in the maintenance of hematopoietic stem cells Blood 1993 82 7 2031 2037 (Pubitemid 23293984)
65. Parmar K., Mauch P., Vergilio J. A., Sackstein R., Down J. D., Distribution of hematopoietic stem cells in the bone marrow according to regional hypoxia Proceedings of the National Academy of Sciences of the United States of America 2007 104 13 5431 5436 (Pubitemid 47175697)
66. Annabi B., Lee Y. T., Turcotte S., Naud E., Desrosiers R. R., Champagne M., Eliopoulos N., Galipeau J., Béliveau R., Hypoxia promotes murine bone-marrow-derived stromal cell migration and tube formation Stem Cells 2003 21 3 337 347 (Pubitemid 36623175)
67. Covello K. L., Kehler J., Yu H., Gordan J. D., Arsham A. M., Hu C. J., Labosky P. A., Simon M. C., Keith B., HIF-2 regulates Oct-4: effects of hypoxia on stem cell function, embryonic development, and tumor growth Genes and Development 2006 20 5 557 570 (Pubitemid 43345322)
68. Iwasaki H., Suda T., Cancer stem cells and their niche Cancer Science 2009 100 7 1166 1172
69. Li H., Fan X., Houghton J., Tumor microenvironment: the role of the tumor stroma in cancer Journal of Cellular Biochemistry 2007 101 4 805 815 (Pubitemid 47040863)
70. Soeda A., Park M., Lee D., Mintz A., Androutsellis-Theotokis A., McKay R. D., Engh J., Iwama T., Kunisada T., Kassam A. B., Pollack I. F., Park D. M., Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1 Oncogene 2009 28 45 3949 3959
71. Hammond E. M., Giaccia A. J., The role of p53 in hypoxia-induced apoptosis Biochemical and Biophysical Research Communications 2005 331 3 718 725 (Pubitemid 40615503)
72. Koshiji M., To K. K., Hammer S., Kumamoto K., Harris A. L., Modrich P., Huang L. E., HIF-1 induces genetic instability by transcriptionally downregulating MutS expression Molecular Cell 2005 17 6 793 803 (Pubitemid 40386941)
73. Tafani M., Di Vito M., Frati A., Pro-inflammatory gene expression in solid glioblastoma microenvironment and in hypoxic stem cells from human glioblastoma Journal of Neuroinflammation 2011 8 32
74. Pistollato F., Abbadi S., Rampazzo E., Persano L., Puppa A. D., Frasson C., Sarto E., Scienza R., D'Avella D., Basso G., Intratumoral hypoxic gradient drives stem cells distribution and MGMT expression in glioblastoma Stem Cells 2010 28 5 851 862
75. Pistollato F., Persano L., Puppa A. D., Rampazzo E., Basso G., Isolation and expansion of regionally defined human glioblastoma cells in vitro Current Protocols in Stem Cell Biology 2011 chapter 3, unit 3.4
76. Bar E. E., Lin A., Mahairaki V., Matsui W., Eberhart C. G., Hypoxia increases the expression of stem-cell markers and promotes clonogenicity in glioblastoma neurospheres The American Journal of Pathology 2010 177 3 1491 1502
77. Mazumdar J., Dondeti V., Simon M. C., Hypoxia-inducible factors in stem cells and cancer Journal of Cellular and Molecular Medicine 2009 13 11-12 4319 4328
78. Pistollato F., Rampazzo E., Abbadi S., Della Puppa A., Scienza R., D'Avella D., Denaro L., te Kronnie G., Panchision D. M., Basso G., Molecular mechanisms of HIF-1 modulation induced by oxygen tension and BMP2 in glioblastoma derived cells PLoS One 2009 4 7
79. Das B., Tsuchida R., Malkin D., Koren G., Baruchel S., Yeger H., Hypoxia enhances tumor stemness by increasing the invasive and tumorigenic side population fraction Stem Cells 2008 26 7 1818 1830
80. Harris A. L., Hypoxiaa key regulatory factor in tumour growth Nature Reviews Cancer 2002 2 1 38 47 (Pubitemid 37328806)
81. Diabira S., Morandi X., Gliomagenesis and neural stem cells: key role of hypoxia and concept of tumor "neo-niche" Medical Hypotheses 2008 70 1 96 104 (Pubitemid 350161161)
82. Seidel S., Garvalov B. K., Wirta V., A hypoxic niche regulates glioblastoma stem cells through hypoxia inducible factor 2 alpha Brain 2010 133 983 995
83. Takahashi K., Yamanaka S., Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors Cell 2006 126 4 663 676 (Pubitemid 44233629)
84. Altaner C., Glioblastoma and stem cells Neoplasma 2008 55 5 369 374
85. Natsume A., Kinjo S., Yuki K., Glioma-initiating cells and molecular pathology: implications for therapy Brain Tumor Pathology 2011 28 1 12
86. Yan X., Ma L., Yi D., A CD133-related gene expression signature identifies an aggressive glioblastoma subtype with excessive mutations Proceedings of the National Academy of Sciences of the United States of America 2011 108 1591 1596
87. Nishide K., Nakatani Y., Kiyonari H., Kondo T., Glioblastoma formation from cell population depleted of prominin1-expressing cells PLoS One 2009 4 8
88. Ogden A. T., Waziri A. E., Lochhead R. A., Fusco D., Lopez K., Ellis J. A., Kang J., Assanah M., McKhann G. M., Sisti M. B., McCormick P. C., Canoll P., Bruce J. N., Identification of A2B5+CD133- tumor-initiating cells in adult human gliomas Neurosurgery 2008 62 2 505 514, discussion 514505 (Pubitemid 351489297)
89. Sato A., Sakurada K., Kumabe T., Sasajima T., Beppu T., Asano K., Ohkuma H., Ogawa A., Mizoi K., Tominaga T., Kitanaka C., Kayama T., Association of stem cell marker CD133 expression with dissemination of glioblastomas Neurosurgical Review 2010 33 2 175 183, discussion 183174
90. Wang J., Sakariassen P. O., Tsinkalovsky O., Immervoll H., Boe S. O., Svendsen A., Prestegarden L., Rosland G., Thorsen F., Stuhr L., Molven A., Bjerkvig R., Enger P. O., CD133 negative glioma cells form tumors in nude rats and give rise to CD133 positive cells International Journal of Cancer 2008 122 4 761 768
91. Prestegarden L., Svendsen A., Wang J., Sleire L., Skaftnesmo K. O., Bjerkvig R., Yan T., Askland L., Persson A., Sakariassen P.., Enger P. O., Glioma cell populations grouped by different cell type markers drive brain tumor growth Cancer Research 2010 70 11 4274 4279
92. Shen Q., Wang Y., Kokovay E., Lin G., Chuang S. M., Goderie S. K., Roysam B., Temple S., Adult SVZ stem cells lie in a vascular niche: a quantitative analysis of niche cell-cell interactions Cell Stem Cell 2008 3 3 289 300
93. Tavazoie M., Van der Veken L., Silva-Vargas V., Louissaint M., Colonna L., Zaidi B., Garcia-Verdugo J. M., Doetsch F., A specialized vascular niche for adult neural stem cells Cell Stem Cell 2008 3 3 279 288
94. Zipori D., The nature of stem cells: state rather than entity Nature Reviews Genetics 2004 5 11 873 878 (Pubitemid 39457503)
95. Spence A. M., Muzi M., Swanson K. R., O'Sullivan F., Rockhill J. K., Rajendran J. G., Adamsen T. C. H., Link J. M., Swanson P. E., Yagle K. J., Rostomily R. C., Silbergeld D. L., Krohn K. A., Regional hypoxia in glioblastoma multiforme quantified with [18F]fluoromisonidazole positron emission tomography before radiotherapy: correlation with time to progression and survival Clinical Cancer Research 2008 14 9 2623 2630
96. Hegi M. E., Diserens A. C., Godard S., Dietrich P. Y., Regli L., Ostermann S., Otten P., Van Melle G., De Tribolet N., Stupp R., Clinical trial substantiates the predictive value of O-6-methylguanine-DNA methyltransferase promoter methylation in glioblastoma patients treated with temozolomide Clinical Cancer Research 2004 10 6 1871 1874 (Pubitemid 38375541)
97. Hegi M. E., Liu L., Herman J. G., Stupp R., Wick W., Weller M., Mehta M. P., Gilbert M. R., Correlation of O6-methylguanine methyltransferase (MGMT) promoter methylation with clinical outcomes in glioblastoma and clinical strategies to modulate MGMT activity Journal of Clinical Oncology 2008 26 25 4189 4199
98. Labussiere M., Wang X. W., Idbaih A., Ducray F., Sanson M., Prognostic markers in gliomas Future Oncology 2010 6 5 733 739
99. Huse J. T., Phillips H. S., Brennan C. W., Molecular subclassification of diffuse gliomas: seeing order in the chaos Glia 2011 59 1190 1199
100. Karayan-Tapon L., Quillien V., Guilhot J., Wager M., Fromont G., Saikali S., Etcheverry A., Hamlat A., Loussouarn D., Campion L., Campone M., Vallette F. M., Gratas-Rabbia-Re C., Prognostic value of O6-methylguanine-DNA methyltransferase status in glioblastoma patients, assessed by five different methods Journal of Neuro-Oncology 2010 97 3 311 322
101. Reardon D. A., Galanis E., DeGroot J. F., Clinical trial end points for high-grade glioma: the evolving landscape Journal of Neuro-Oncology 2011 13 353 361
102. Cao V. T., Jung T. Y., Jung S., Jin S. G., Moon K. S., Kim I. Y., Kang S. S., Park C. S., Lee K. H., Chae H. J., The correlation and prognostic significance of MGMT promoter methylation and MGMT protein in glioblastomas Neurosurgery 2009 65 5 866 875
103. Cheng L., Bao S., Rich J. N., Potential therapeutic implications of cancer stem cells in glioblastoma Biochemical Pharmacology 2010 80 5 654 665
104. Coma S., Shimizu A., Klagsbrun M., Hypoxia induces tumor and endothelial cell migration in a semaphorin 3F- and VEGF-dependent manner via transcriptional repression of their common receptor neuropilin 2 Cell Adhesion Migration 2011 5 266 275
105. Cronin P. A., Wang J. H., Redmond H. P., Hypoxia increases the metastatic ability of breast cancer cells via upregulation of CXCR4 BMC Cancer 2010 10, article 225
106. Piovan E., Tosello V., Indraccolo S., Masiero M., Persano L., Esposito G., Zamarchi R., Ponzoni M., Chieco-Bianchi L., Dalla-Favera R., Amadori A., Differential regulation of hypoxia-induced CXCR4 triggering during B-cell development and lymphomagenesis Cancer Research 2007 67 18 8605 8614 (Pubitemid 47437436)
107. Quinones-Hinojosa A., Sanai N., Gonzalez-Perez O., Garcia-Verdugo J. M., The human brain subventricular zone: stem cells in this niche and its organization Neurosurgery Clinics of North America 2007 18 15 20 (Pubitemid 46164760)
108. Lin S. H., Kleinberg L. R., Carmustine wafers: localized delivery of chemotherapeutic agents in CNS malignancies Expert Review of Anticancer Therapy 2008 8 3 343 359 (Pubitemid 351836283)
109. Fleming A. B., Saltzman W. M., Pharmacokinetics of the carmustine implant Clinical Pharmacokinetics 2002 41 6 403 419 (Pubitemid 34753678)